RFK Jr. defends $500M cut for mRNA vaccines with pseudoscience gobbledygook

RFK Jr. defends $500M cut for mRNA vaccines with pseudoscience gobbledygook

In a recent social media post, Robert F. Kennedy Jr., the US health secretary known for his anti-vaccine stance, made headlines by announcing the cancellation of nearly $500 million in funding for mRNA vaccine research aimed at combating potential pandemics. The funding, which is being revoked from 22 contracts managed by the Biomedical Advanced Research and Development Authority (BARDA), underscores Kennedy's long-standing opposition to vaccines, particularly mRNA technology. Kennedy's announcement comes on the heels of his continued criticism of mRNA vaccines, which gained prominence during the COVID-19 pandemic. Despite their rapid development and significant impact, he has repeatedly disseminated misleading information about their efficacy. In his latest video, Kennedy claimed that mRNA vaccines are ineffective against upper respiratory viruses, a statement that contradicts the evidence showing that COVID-19 vaccines have saved over 3 million lives in the U.S. alone and prevented more than 18 million hospitalizations during the pandemic. The video further delves into Kennedy's controversial assertions, suggesting that mRNA vaccines promote viral mutations due to their mechanism, which he claims could prolong pandemics. However, this perspective fails to accurately represent how mRNA vaccines function. By introducing a small segment of genetic material into cells, these vaccines train the immune system to recognize and combat actual viruses. This process is crucial for mounting effective defenses against infections. Kennedy's rhetoric raises significant concerns among public health experts, who emphasize the importance of mRNA technology in modern medicine. As debates around vaccine funding and scientific integrity continue, the implications of such decisions could profoundly affect future pandemic preparedness and response efforts.

Sources : Ars Technica

Published On : Aug 07, 2025, 11:25

AI
OpenAI Strengthens Leadership with Greg Brockman Amid Strategic Shift

OpenAI has appointed Greg Brockman as the new leader overseeing its key projects, following the resignation of Fidji Sim...

CNBC | Jul 10, 2026, 19:25
OpenAI Strengthens Leadership with Greg Brockman Amid Strategic Shift
Startups
Apple Stock Surges to New Heights Amid AI Hype

In an impressive display of market resilience, Apple Inc. has seen its stock price climb to unprecedented levels, largel...

CNBC | Jul 10, 2026, 20:25
Apple Stock Surges to New Heights Amid AI Hype
AI
The Shift in AI: From Size to Smart Solutions

The landscape of artificial intelligence is undergoing a significant transformation. For the past couple of years, the c...

CNBC | Jul 10, 2026, 21:35
The Shift in AI: From Size to Smart Solutions
Startups
Apple Files Lawsuit Against OpenAI Over Allegations of Trade Secret Misappropriation

In a dramatic turn of events, Apple has initiated legal action against OpenAI in a federal court located in Northern Cal...

CNBC | Jul 10, 2026, 20:45
Apple Files Lawsuit Against OpenAI Over Allegations of Trade Secret Misappropriation
Aerospace
China Advances in Reusable Rocket Technology, Challenging SpaceX's Dominance

China's state-owned space agency has made significant strides in reusable rocket technology, successfully launching a Lo...

TechCrunch | Jul 10, 2026, 17:15
China Advances in Reusable Rocket Technology, Challenging SpaceX's Dominance
View All News